Disclosure Panels Details Page
Pancreatic Adenocarcinoma Panel - Disclosures as of 06/30/2024
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Ajibola Awotiwon MBBS,MSc | None | None | None | None | 05/28/2024 |
| Al Benson III MD,FACP,FASCO | AIM Immuno Tech Astellas Pharma US, Inc. Boehringer Ingelheim GmbH Bristol Myers Squibb GSK Mirati Mirati Therapeutics, Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. PrECOG, LLC Tempus Terumo Therabionic |
Therabionic AIM Immuno Tech Amgen Inc. Apexigen Astellas Pharma US, Inc. AVEO Pharmaceuticals, Inc. Bayer HealthCare Boehringer Ingelheim GmbH Bristol Myers Squibb GSK Halio Mirati Mirati Therapeutics Natera Novartis Pharmaceuticals Corporation Pfizer Inc./Hospira Inc. Replimune Tempus Terumo |
None | None | 05/03/2024 |
| Marian Birkeland PhD | None | None | None | None | 04/02/2024 |
| Nicole Blankenhorn | None | None | None | None | 03/04/2024 |
| Dana Cardin MD | Elicio Therapeutics Novartis Pharmaceuticals Corporation XBiotech |
None | None | National Cancer Institute | 06/24/2024 |
| Elena Gabriela Chiorean MD | AffiniT Biosplice Boehringer Ingelheim GmbH Bristol Myers Squibb Erasca Genentech, Inc. Gilead Sciences, Inc. Lonza |
Bristol Myers Squibb Merus Regeneron Pharmactcls |
None | None | 06/07/2024 |
| Jared Christensen MD | None | None | None | None | 06/18/2024 |
| Vincent Chung MD | None | Perthera | None | None | 05/16/2024 |
| Brian Czito MD | Galera Pharm | None | Varian Medical Systems, Inc. | UpToDate | 06/02/2023 |
| Marco Del Chiaro MD,PhD | Boston Scientific Corporation Haemonetics, Inc |
None | None | None | 06/06/2024 |
| Mary Dillhoff MS,MD | None | None | None | None | 07/20/2023 |
| Timothy Donahue MD | None | Trethera Corporation | None | Trethera Corporation | 05/30/2024 |
| Efrat Dotan MD | Dragonfly Illy Lilly Ipsen Kinate Lutris NGM Biopharmaceuticals Inc. RELAY THERAPEUTICS, INC. Zymeworks |
Agents Amgen Inc. Olympus |
None | None | 05/02/2024 |
| Christos Fountzilas MD,FACP | Bellicum Alliance for Clinical Trials In Oncology Amgen Inc. Aravive, Inc. Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP Biomea Fusion CG Pharmaceuticals Compass Therapeutics Department of Defense Genentech, Inc. Genfit Gilead Sciences, Inc. HOOSIER ONCOLOGY GROUP Ipsen Kadmon Legend Biotech MedImmune Inc. Merck & Co., Inc. Mirati Therapeutics National Cancer Institute National Comprehensive Cancer Network Neuroendocrine Tumor Research Foundation Nouscom Palleon Pharmaceuticals Pfizer Inc. Replimune Simcha Therapeutics SWOG Taiho Pharmaceuticals Co., Ltd. TransThera Biosciences Triumvira Immunologics University of Pennsylvania Valar Labs Weill Cornell Medicine Werewolf Therapeutics |
None | None | None | 04/10/2024 |
| Evan Glazer PhD,MD,FACS | Delcath | Anviron | None | None | 05/15/2024 |
| Kristina Gregory MSN,RN | None | None | None | None | 05/27/2024 |
| Evelyn Handel PharmD,BCPS,BCOP | None | None | None | None | 06/18/2024 |
| Laura Hanisch PsyD | None | None | None | None | 06/12/2024 |
| Jeffrey Hardacre MD | None | None | None | None | 05/01/2024 |
| Kyle Herrmann OCN,RN,BSN | None | None | None | None | 04/29/2024 |
| Erin Hesler | None | None | None | None | 05/08/2024 |
| Anne Holbrook PharmD,BCOP | None | None | None | None | 05/16/2024 |
| Kelsey Klute MD | AstraZeneca Pharmaceuticals LP Cardiff Oncology, Inc |
None | None | None | 11/21/2023 |
| Andrew Ko MD | Apexigen Biomed Valley Bristol Myers Squibb Genentech, Inc. Grail Leap Therapeutics Novartis Pharmaceuticals Corporation Pancreatic Cancer Action Network (PanCAN) Parker Institute for Cancer Immunotherapy Roche Laboratories, Inc. Verastem |
Arcus Astellas Pharma US, Inc. Eisai Inc. Fibrogen Lewis Brisbois |
None | None | 06/18/2024 |
| John Kunstman MD,MHS | None | Legal Consulting - drafting opinion without testimony for surgical cases unrelated to pancreatic cancer | None | None | 08/30/2023 |
| Kian Lim PhD,MD | Genentech, Inc. | None | CURIS LLC | Aclaris LLC | 04/15/2024 |
| Noelle LoConte MD | Exact Sciences | None | None | None | 06/26/2024 |
| Andrew Lowy MD | None | Expert witness consulting Kinnate Silexion Steba biotech |
Boehringer Ingelheim GmbH Revolution Medicines |
None | 05/02/2024 |
| Mokenge Malafa MD,FACS | None | None | None | None | 01/25/2024 |
| Ashiq Masood MD | Amgen Inc. AstraZeneca Pharmaceuticals LP Eli Lilly and Company Genentech, Inc. Gritstone Hoosier Network Ipsen Merck & Co., Inc. National Cancer Institute Novocure SWOG Taiho Pharmaceuticals Co., Ltd. |
Patient case witness | None | None | 01/05/2024 |
| Cassadie Moravek BS | None | None | None | None | 05/01/2024 |
| Eric Nakakura MD | None | None | None | None | 06/13/2024 |
| Amol Narang MD | Boston Scientific Corporation | None | None | None | 03/19/2024 |
| Lorenzo Nardo PhD,MD | Curium European Commission General Electric NIH: I am the Co-Pi of 2 NIH grants as reported in NIH RePORT Novartis Pharmaceuticals Corporation Progenics/lantheus Telix Pharmaceuticals United Imaging Healthcare |
Eli Lilly and Company | None | None | 04/02/2024 |
| Jorge Obando MD | None | None | None | None | 05/12/2024 |
| Patricio Polanco MD | None | Intuitive Surgical IOTA Biosciences Pallisade Bio |
None | None | 02/22/2024 |
| George Poultsides MS,MD,FACS | None | None | None | None | 04/15/2024 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 03/13/2024 |
| Swathi Ramakrishnan PhD | None | None | None | None | 04/22/2024 |
| Sushanth Reddy MD | None | None | None | None | 06/07/2024 |
| Marsha Reyngold PhD,MD | None | None | None | None | 04/23/2024 |
| Courtney Scaife MD | None | None | None | None | 05/14/2024 |
| Ardaman Shergill MD | Research (to institution): Hutchison MediPharma, Takeda, Merck, Verastem Oncology, Turning Point Therapeutics, Gritstone, Bolt Therapeutics, BMS, Pfizer, Astellas, Oncologie, Macogenics, Seattle Genetics, Amgen, Daiichi, Lilly, Jacobio, Astrazeneca, Jazz pharma, Agenus | Advisory Board participation: Merus, Regeneron/Sanofi, Pfizer and Catalyst Pharmaceuticals | Speaking: Great Debates in GI oncology, OncLive, OSCO/ASCO Direct, ACPMP, Cholangiocarcinoma Summit, Cholangiocarcinoma Foundation, ASCO Advantage | None | 06/27/2024 |
| Margaret Tempero MD | None | Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP BeiGene Bio Ascend-B2ACT Therapeutics Genex Biomea Fusion Inc. BioSapiens Biotech Research Boehringer Ingelheim GmbH Bristol Myers Squibb Debiopharm ElmediX Exact Sciences Geistlich Pharma Geron Corporation Global Bio Access Fund Ipsen Merus Mirati Therapeutics Inc. Novartis Pharmaceuticals Corporation Oncolytics Peptomyc, S.L |
None | None | 02/06/2024 |
| Mark Truty MS,MD | None | None | None | None | 05/22/2024 |
| Charles Vollmer, Jr. MD | Intuitive Surgical, Inc. | Expert witness for a malpractice trial | None | None | 04/21/2024 |
| Robert Wolff MD | None | None | None | McGraw-Hill | 06/06/2024 |
| Brian Wolpin MD,MPH | (Agios) Servier Agios, Inc. AstraZeneca Pharmaceuticals LP Celgene Corporation Eli Lilly and Company Harbinger Health Ipsen Novartis Pharmaceuticals Corporation Revolution Medicines Third Rock Ventures |
Agenus Inc Celgene Corporation EcoR1 Capital Grail Mirati Therapeutics, Inc. |
None | None | 02/27/2024 |